Advertisement

148 Results

for author "Haesook T. Kim"

Type a term to search within all articles in this journal: e.g., stem cell
Citation
Citation-specific search information
e.g., 2009
e.g., 20
e.g., 3
e.g., 29
e.g., 10.9999/123XYZ456
Authors, Keywords
Search for specific authors and/or words and phrases.
e.g., Smith, JS
e.g., Smith, JS
Type any phrase that appears in the article title
Type any phrase that appears within article title or abstract
Type any phrase that appears within article body, title or abstract
e.g., Smith, JS
Book publisher name
Limit Results
Limit search results by date
Date of Publication
e.g., 2017-01-17
e.g., 2017-01-17
Format Results
  • Functional Effects of Low-Dose IL-2 in Patients with Chronic Graft Versus Host Disease
    Jennifer Whangbo, Bryn Falahee, John Koreth, Haesook T. Kim, Sarah Nikiforow, Vincent T. Ho, Corey S. Cutler, Philippe Armand, Edwin P. Alyea, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz
    ...Armand Philippe Sarah Whangbo, Jennifer Cutler, C Falahee R Soiffer Edwin P, Alyea Whangbo, J Haesook T Robert J, Soiffer Corey Cutler HT Kim Cutler, Corey S Jerome, Ritz Bryn Falahee Cutler, CS RobertJ Soiffer Corey S, Cutler Philippe, Armand Joseph Antin Alyea, E.P Haesook T, Kim Haesook T Kim Ho, V ~~~
  • TGR-1202 in Combination with Ibrutinib in Patients with Relapsed or Refractory CLL or MCL: Preliminary Results of a Multicenter Phase I/Ib Study
    Matthew S. Davids, Haesook T. Kim, Alyssa Nicotra, Alexandra Savell, Karen Francoeur, Jeffrey Hellman, Hari P. Miskin, Peter Sportelli, Asad Bashey, Laura Stampleman, Jens Rueter, Adam Boruchov, Jon Arnason, Caron A. Jacobson, David C. Fisher, Jennifer R. Brown
    ..., Alexandra David C, Fisher Alyssa Nicotra Francoeur, K Karen HT Kim H Miskin Matthew S, Davids Savell Davids, M Jacobson, C.A Miskin, H.P Jacobson, C Asad, Bashey Haesook T Kim Haesook T, Kim Jeffrey Hellman Haesook Kim Francoeur Brown, J K Francoeur Jon, Arnason D.C. Fisher Nicotra Alyssa HP Miskin ~~~
  • Initial Results of a Multicenter, Phase II Study of Ibrutinib Plus FCR (iFCR) As Frontline Therapy for Younger CLL Patients
    Matthew S. Davids, Haesook T. Kim, Danielle M. Brander, Jad Bsat, Alexandra Savell, Karen Francoeur, Jeffrey Hellman, Caron A. Jacobson, Ephraim Hochberg, Ronald Takvorian, Jeremy S. Abramson, David C. Fisher, Jennifer R. Brown
    ...D.M. Brander J Brown Haesook T Danielle M Brander Savell, Alexandra David C, Fisher Francoeur, K HT Kim Karen Matthew S, Davids Jad Bsat Savell Davids, M Jeremy S J Bsat Jacobson, C.A R Takvorian Jacobson, C Ephraim Brander, DM Haesook T Kim Haesook T, Kim Bsat Jad Jeffrey Hellman Brander Danielle M ~~~
  • BK Virus-Specific T Cell Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
    Eduardo Espada, Ann E. Woolley, Jason Avigan, Edouard Forcade, Maria V.D. Soares, Sarah Nikiforow, Vincent T. Ho, Corey S. Cutler, John Koreth, Philippe Armand, Edwin P. Alyea, Robert J. Soiffer, Joseph H. Antin, João F. Lacerda, Haesook T. Kim, Francisco M. Marty, Jerome Ritz
    ...Cutler A Woolley Cutler, Corey S HT Kim Jerome, Ritz Avigan, J Cutler, CS Philippe, Armand RobertJ Soiffer Ann E Woolley Joseph Antin JF Lacerda Lacerda, J Haesook T Kim MV Soares Edwin Alyea Haesook Kim Ann E, Woolley J Avigan Marty, Francisco M Francisco Avigan Jason Corey S Cutler Kim Haesook T ~~~
  • Bortezomib-Based Versus Standard of Care Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation: A Phase II Randomized Controlled Trial
    John Koreth, Haesook T. Kim, Paulina B Lange, Philippe Armand, Corey S. Cutler, Vincent T. Ho, Brett Glotzbecker, Rushdia Z. Yusuf, Sarah Nikiforow, Bimalangshu R. Dey, Malgorzata McMasters, Jerome Ritz, Bruce R. Blazar, Robert J. Soiffer, Joseph H Antin, Edwin P. Alyea
    ...Bortezomib-Based Versus Standard of Care Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation: A Phase II Randomized Controlled Trial John Koreth , MD 1 , Haesook T. Kim , PhD * , 2 , Paulina B Lange * , 3 , Philippe Armand ~~~
  • Circulating T follicular helper cells with increased function during chronic graft-versus-host disease
    Edouard Forcade, Haesook T. Kim, Corey Cutler, Kathy Wang, Ana C. Alho, Sarah Nikiforow, Vincent T. Ho, John Koreth, Philippe Armand, Edwin P. Alyea, Bruce R. Blazar, Robert J. Soiffer, Joseph H. Antin, Jerome Ritz
    ...Circulating T follicular helper cells with increased function during chronic graft-versus - host disease Edouard Forcade 1 , 2 , 3 , Haesook T. Kim 4 , 5 , Corey Cutler 1 , 2 , Kathy Wang 1 , 2 , Ana C. Alho 1 , 2 , Sarah ~~~
  • A Prospective Randomized Double Blind Phase 3 Clinical Trial of Anti- T Lymphocyte Globulin (ATLG) to Assess Impact on Chronic Graft-Versus-Host Disease (cGVHD) Free Survival in Patients Undergoing HLA Matched Unrelated Myeloablative Hematopoietic Cell Transplantation (HCT)
    Robert J. Soiffer, Haesook T. Kim, Joseph McGuirk, Mitchell E. Horwitz, Laura Johnston, Mrinal M Patnaik, Witold Rybka, Andrew Artz, David L Porter, Thomas C. Shea, Michael W Boyer, Richard T. Maziarz, Madan H. Jagasia, Paul J. Shaughnessy, Usama Gergis, Hana Safah, Ran Reshef, John F. DiPersio, Patrick J. Stiff, Madhuri Vusirikala, Jeff Szer, Jennifer Holter, James D. Levine, Paul J. Martin, Joseph A. Pidala, Ian D. Lewis, Vincent T. Ho, Edwin P. Alyea, Jerome Ritz, Frank Glavin, Peter Westervelt, Yi-Bin Chen
    ..., MH Haesook T Paul J Shaughnessy Mitchell Johnston, L HT Kim Jerome, Ritz John F, DiPersio Andrew Porter, DL RobertJ Soiffer Peter, Westervelt Lewis, ID Frank, Glavin IanD Lewis M.H. Jagasia JF DiPersio J Pidala Haesook T Kim R.T. Maziarz F Glavin John F Lewis David L T Shea Edwin Alyea Haesook Kim ~~~
  • Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
    Benjamin L. Lampson, Siddha N. Kasar, Tiago R. Matos, Elizabeth A. Morgan, Laura Rassenti, Matthew S. Davids, David C. Fisher, Arnold S. Freedman, Caron A. Jacobson, Philippe Armand, Jeremy S. Abramson, Jon E. Arnason, Thomas J. Kipps, Joshua Fein, Stacey Fernandes, John Hanna, Jerome Ritz, Haesook T. Kim, Jennifer R. Brown
    ...Caron A Jacobson Tiago R Matos J Arnason Laura Rassenti Rassenti Laura L Rassenti Tiago R, Matos Elizabeth A David Fisher T Kipps T.J. Kipps A.S. Freedman TJ Kipps J Brown Stacey TiagoR Matos Haesook T HT Kim Jerome, Ritz Arnold S Matthew S, Davids Philippe, Armand Laura, Rassenti Fein Haesook T Kim ~~~
  • Preliminary Results of a Phase Ib Study of Duvelisib in Combination with FCR (dFCR) in Previously Untreated, Younger Patients with CLL
    Matthew S. Davids, Haesook T. Kim, Elizabeth Gilbert, Leslie Cowen, Karen Francoeur, Jeffrey Hellman, Jon E. Arnason, David C. Fisher, Jennifer R. Brown
    ..., Fisher Francoeur, K Karen HT Kim Arnason, J.E Leslie Cowen Matthew S, Davids Elizabeth, Gilbert Davids, M Haesook T Kim Haesook T, Kim E Gilbert Jeffrey Hellman Haesook Kim Francoeur Brown, J K Francoeur JE Arnason D.C. Fisher Leslie Hellman Jeffrey Jeffrey MS Davids DavidC Fisher David C Fisher David C ~~~
  • A Phase II Study of Ofatumumab-High Dose Methylprednisolone Followed By Ofatumumab-Alemtuzumab in 17p Deleted or TP53 Mutated CLL
    Matthew S. Davids, Haesook T. Kim, Stacey M. Fernandes, Jeffrey Hellman, Karen Francoeur, Jon E. Arnason, Eric Jacobsen, Ann S LaCasce, David C. Fisher, Jennifer R. Brown
    ...M Fernandes J Brown Stacey Fernandes, S.M Haesook T David C, Fisher Francoeur, K HT Kim Karen Arnason, J.E Jacobsen Eric Matthew S, Davids Davids, M LaCasce Ann S Eric, Jacobsen LaCasce, A Fernandes Stacey M. Haesook T Kim Haesook T, Kim Jeffrey Hellman Haesook Kim Francoeur Brown, J K Francoeur JE Arnason D ~~~

Pages